You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DYN Sale Disclosure
Kerr Douglas · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$40.89K
Kerr Douglas Chief Medical Officer
DYN
Transaction date
Aug 13, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 4 days later
DYN daily price context
Close on/before transaction
$25.96
Aug 13, 2026
First close after public filing
$26
Aug 18, 2026
30-day return after filing
-33.44%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,556 shares @ $26.28
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001814189-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$40.89K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN Current | Sale | Aug 13, 2026 | $40.89K |